Allow more companies to list while ensuring fair treatment to investors
At a crossroads between ambition and prudence, Hong Kong's Securities and Futures Commission is quietly reexamining the rules that determine which companies may enter its public markets. Under chair Kelvin Wong, the regulator is weighing whether to extend the openings made in 2018 — when pre-revenue biotechs and dual-class share structures were first permitted — to a broader universe of technology enterprises. The effort reflects a city conscious of its slipping position among Asian financial centers, yet unwilling to sacrifice the investor protections that underpin its credibility.
- Hong Kong has been steadily losing tech IPOs to Singapore, Shanghai, and global exchanges, creating quiet urgency inside the city's financial establishment.
- The SFC's formal review signals that the 2018 reforms, once considered bold, may no longer be sufficient to keep pace with a rapidly evolving regional competition.
- Chair Kelvin Wong has been careful to frame the effort as a balancing act, invoking 'sufficient investor protection' repeatedly to signal that openness will not come at the cost of market integrity.
- No timeline has been set and no target sectors named, leaving founders, investors, and rival exchanges in a state of watchful uncertainty.
- The unresolved questions — whether unprofitable software firms can list, whether founders can retain outsized voting control — will ultimately define how far Hong Kong is truly willing to go.
Hong Kong's Securities and Futures Commission is conducting a formal review of its listing requirements, with the aim of attracting a new generation of technology companies to the city's exchange. Chair Kelvin Wong Tin-yau outlined the effort at a media briefing, describing it as a careful balance between expanding access and preserving the standards that protect ordinary investors.
The backdrop is competitive pressure. Hong Kong has watched IPO activity migrate toward Singapore, Shanghai, and Western exchanges in recent years. A pivotal shift came in 2018, when the exchange allowed pre-revenue biotech companies and firms with multiple voting share classes to list — a meaningful departure from the city's traditionally profit-focused requirements. The current review asks whether that opening should be widened further.
Wong's language was deliberate. He confirmed the review is ongoing but offered no timeline or specific targets, only a clear directional signal: more companies should be able to access Hong Kong's capital markets without dismantling the safeguards already in place. The phrase 'sufficient investor protection' featured prominently, suggesting the SFC is alert to the risks that come with less-proven business models and founder-controlled structures.
The deeper questions remain open. Whether unprofitable software firms, founders with minimal equity but maximum voting power, or entirely new categories of tech enterprise will qualify under any reformed framework is still unresolved. Those answers will shape not only Hong Kong's IPO landscape but its longer-term standing as a global financial center. For now, the review proceeds quietly, and the market watches.
Hong Kong's financial regulator is quietly reshaping the rules that govern which companies can go public, aiming to lure a new generation of technology firms to its exchange. The Securities and Futures Commission, led by chair Kelvin Wong Tin-yau, is conducting a formal review of listing requirements that could open the door to smaller, faster-growing tech enterprises that might otherwise choose to list elsewhere. Wong outlined the effort during a media briefing on Tuesday, framing it as a balancing act between ambition and caution.
The city has been losing ground to Singapore, Shanghai, and other regional rivals in the race to capture tech IPOs. For years, Hong Kong's listing rules were rigid—companies needed to be profitable, or at least have a clear path to profitability, before they could go public. That began to shift in 2018, when the exchange introduced a new framework that allowed pre-revenue biotechnology companies and firms with multiple classes of voting shares to list. It was a significant loosening, designed to keep pace with global markets and prevent promising startups from fleeing to New York or Nasdaq.
Now the regulator is considering whether to push further. Wong said the review has not yet concluded, but the direction is clear: expand the tent. The goal is to allow a wider range of enterprises to access Hong Kong's capital markets under the existing 2018 framework, without dismantling the safeguards that protect ordinary investors. "The regulatory principle here is to ensure the overall market quality of Hong Kong," Wong said. "The reform will focus on whether it can allow more companies to list under the regime while at the same time ensuring fair treatment to investors."
The language is measured, almost cautious. Wong offered no timeline for when the review might conclude, and he did not specify which sectors or company types might be targeted. But the subtext is urgent. Hong Kong's stock exchange has seen its share of IPO activity decline in recent years, and the city's status as a global financial hub depends partly on its ability to attract the next generation of wealth creators. A more permissive listing regime could help. It could also introduce new risks—companies with unproven business models, founders with outsized control, and investors who may not fully understand what they are buying.
Wong's framing suggests the SFC is aware of both possibilities. The phrase "sufficient investor protection" appears twice in his remarks, a signal that the regulator will not simply rubber-stamp applications from any startup with a good pitch deck. The review will attempt to thread a needle: making Hong Kong more attractive to ambitious tech founders while ensuring that retail investors—the people who buy shares through their brokers—are not left holding the bag when a company fails to deliver on its promises.
What remains unclear is how far the regulator is willing to go. Will it allow unprofitable software companies to list? Will it permit founders to retain voting control even as they own a small fraction of the company? Will it create new disclosure requirements or investor education mandates? These questions will shape not just Hong Kong's IPO market, but the city's broader economic trajectory. For now, the review continues behind closed doors, and the market waits.
Citas Notables
The regulatory principle here is to ensure the overall market quality of Hong Kong. The reform will focus on whether it can allow more companies to list under the regime while at the same time ensuring fair treatment to investors.— Kelvin Wong Tin-yau, SFC chair
La Conversación del Hearth Otra perspectiva de la historia
Why is Hong Kong suddenly worried about losing tech listings? Isn't it already a major financial hub?
It is, but the region has shifted. Singapore, Shanghai, and other cities have become more aggressive about courting startups. Hong Kong's old rules were too strict—you basically had to prove you could make money before you could go public. That scared away a lot of promising young companies.
So they're just going to let anyone list now?
No, that's the tension. They want to be more open, but they're also terrified of another bubble or scandal. The regulator keeps saying "investor protection" because they know that if retail investors get burned on a bad listing, it damages confidence in the whole market.
What changed in 2018?
They created an exception for biotech companies that hadn't made any money yet, and for companies where founders could keep control even if they didn't own most of the shares. It was a big shift. Now they're asking whether to expand that further.
To what kind of companies?
That's the question nobody's answering yet. Tech firms, probably. Software companies, maybe fintech. But they haven't said which ones or how far they'll go.
When will we know?
They didn't give a timeline. The review is still happening. It could take months, maybe longer. But the direction is set—they want to open the door wider.
What's the real risk here?
You end up with a market full of companies that look great on paper but can't actually execute. Investors lose money. Trust erodes. That's what the regulator is trying to avoid.